SMS PHARMACEUTICALS
Back to Cashflow Statement
|
SMS PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹31 Cr | ₹-32 Cr | ₹-12 Cr | ₹92 Cr | ₹-2.40 Cr |
What is the latest Cash Flow from Financing Activities ratio of SMS PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹31 Cr |
Mar2023 | ₹-32 Cr |
Mar2022 | ₹-12 Cr |
Mar2021 | ₹92 Cr |
Mar2020 | ₹-2.40 Cr |
How is Cash Flow from Financing Activities of SMS PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹31 Cr | Positive | |
Mar2023 | ₹-32 Cr | Negative | |
Mar2022 | ₹-12 Cr | Negative | |
Mar2021 | ₹92 Cr | Positive | |
Mar2020 | ₹-2.40 Cr | - |
Compare Cash Flow from Financing Activities of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,737.6 Cr | 2.1% | -16.9% | 53.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | 2.1% |
-16.9% |
53.2% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses